Cordis announced that its Selution SLR Sustane percutaneous transluminal angioplasty (PTA) sirolimus drug-eluting balloon ...

Penumbra, Inc., announced new STORM-PE findings examining the relationship between activity recorded by wearable devices and cli ...

Balt announced that the first patients in North America have been enrolled in its premarket approval clinical trial, PIONEER, ...

Endologix Holdings, LLC, announced that its new corporate brand is Rhevera Medical. According to its press release, Rhevera ( ...

Terumo Neuro announced that it has signed an agreement to acquire Arsenal Medical Inc., which is developing NeoCast, a ...

Inquis Medical, a developer of treatments for venous thromboembolic disease, announced the United States commercial launch of ...

Gore & Associates announced that the first patients were enrolled in the pivotal study of the company’s investigationa ...

Medtronic announced it has received Breakthrough Device designation from the FDA for its In.Pact below-the-knee (BTK) paclitaxel ...

September 29, 2026—iVascular announced new phase 2 data from the OPAL study of Amber, the company’s liquid embolic. The ...

The Society of Interventional Radiology (SIR) announced the publication of a study demonstrating that embolization greatly re ...

The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) announced the start of patient enrollment in the ...

Route 92 Medical, Inc. announced FDA 510(k) clearance for the FreeClimb 46 catheter with Tenzing 4. The two components are en ...